Hiroyuki Sasaki1, Ai Hirasawa2, Takuro Washio1, Shigehiko Ogoh3. 1. Department of Biomedical Engineering, Toyo University, 2100 Kujirai, Kawagoe, Saitama, 350-8585, Japan. 2. Advanced Triage Team, Kyorin University School of Medicine, Mitaka, Tokyo, Japan. 3. Department of Biomedical Engineering, Toyo University, 2100 Kujirai, Kawagoe, Saitama, 350-8585, Japan. ogoh@toyo.jp.
Abstract
PURPOSE: Drinking coffee causes caffeine-induced physiological alterations such as increases in arterial blood pressure, sympathetic nerve activity, cerebral vasoconstriction, etc., and these physiological alterations may be associated with a reduced risk of cerebral vascular disease. However, the effect of coffee drinking on dynamic cerebral blood flow (CBF) regulation remains unclear. The aim of this study was to test our hypothesis that coffee drinking enhances dynamic cerebral autoregulation. METHOD: Twelve healthy young subjects participated in the present study. After a 5 min baseline measurement in a semi-recumbent position on the hospital bed, each subject drank water (CON) as a placebo condition or coffee beverage (Coffee INT). Arterial blood pressure and middle cerebral artery blood velocity (MCAv) were measured continuously throughout the experiment. At 30 min after the intake of either water or coffee, dynamic cerebral autoregulation was examined using a thigh cuffs occlusion and release technique. Each condition was randomly performed on a different day. RESULT: Under Coffee INT condition, mean arterial blood pressure was increased (P = 0.01) and mean MCAv was decreased (P = 0.01) from the baseline. The rate of regulation (RoR), as an index of dynamic cerebral autoregulation, during coffee condition was significantly higher than that during CON (P = 0.0009). CONCLUSION: The findings of the present study suggest that coffee drinking augments dynamic CBF regulation with cerebral vasoconstriction. This phenomenon may be associated with a reduction in the risk of cerebral vascular disease.
RCT Entities:
PURPOSE: Drinking coffee causes caffeine-induced physiological alterations such as increases in arterial blood pressure, sympathetic nerve activity, cerebral vasoconstriction, etc., and these physiological alterations may be associated with a reduced risk of cerebral vascular disease. However, the effect of coffee drinking on dynamic cerebral blood flow (CBF) regulation remains unclear. The aim of this study was to test our hypothesis that coffee drinking enhances dynamic cerebral autoregulation. METHOD: Twelve healthy young subjects participated in the present study. After a 5 min baseline measurement in a semi-recumbent position on the hospital bed, each subject drank water (CON) as a placebo condition or coffee beverage (Coffee INT). Arterial blood pressure and middle cerebral artery blood velocity (MCAv) were measured continuously throughout the experiment. At 30 min after the intake of either water or coffee, dynamic cerebral autoregulation was examined using a thigh cuffs occlusion and release technique. Each condition was randomly performed on a different day. RESULT: Under Coffee INT condition, mean arterial blood pressure was increased (P = 0.01) and mean MCAv was decreased (P = 0.01) from the baseline. The rate of regulation (RoR), as an index of dynamic cerebral autoregulation, during coffee condition was significantly higher than that during CON (P = 0.0009). CONCLUSION: The findings of the present study suggest that coffee drinking augments dynamic CBF regulation with cerebral vasoconstriction. This phenomenon may be associated with a reduction in the risk of cerebral vascular disease.
Authors: Esther Lopez-Garcia; Rob M van Dam; Walter C Willett; Eric B Rimm; JoAnn E Manson; Meir J Stampfer; Kathryn M Rexrode; Frank B Hu Journal: Circulation Date: 2006-04-24 Impact factor: 29.690
Authors: Rong Zhang; Julie H Zuckerman; Kenichi Iwasaki; Thad E Wilson; Craig G Crandall; Benjamin D Levine Journal: Circulation Date: 2002-10-01 Impact factor: 29.690
Authors: Joseph R Meno; Thien-son K Nguyen; Elise M Jensen; G Alexander West; Leonid Groysman; David K Kung; Al C Ngai; Gavin W Britz; H Richard Winn Journal: J Cereb Blood Flow Metab Date: 2005-06 Impact factor: 6.200
Authors: Marlies Noordzij; Cuno S P M Uiterwaal; Lidia R Arends; Frans J Kok; Diederick E Grobbee; Johanna M Geleijnse Journal: J Hypertens Date: 2005-05 Impact factor: 4.844
Authors: Shigehiko Ogoh; Paul J Fadel; Peter Nissen; Øeivind Jans; Christian Selmer; Niels H Secher; Peter B Raven Journal: J Physiol Date: 2003-05-02 Impact factor: 5.182
Authors: Iain T Parsons; Brooke C D Hockin; Omnia M Taha; Natalie D Heeney; Erin L Williams; Vera-Ellen M Lucci; Rebekah H Y Lee; Michael J Stacey; Nick Gall; Phil Chowienczyk; David R Woods; Victoria E Claydon Journal: Clin Auton Res Date: 2022-04-23 Impact factor: 5.625